Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Novel RNA interference-based therapies for sepsis.

Kosovrasti VY, Lukashev D, Nechev LV, Amiji MM.

Expert Opin Biol Ther. 2014 Apr;14(4):419-35. doi: 10.1517/14712598.2014.875524. Epub 2014 Jan 8. Review.

PMID:
24397825
2.

Therapeutic face of RNAi: in vivo challenges.

Borna H, Imani S, Iman M, Azimzadeh Jamalkandi S.

Expert Opin Biol Ther. 2015 Feb;15(2):269-85. doi: 10.1517/14712598.2015.983070. Epub 2014 Nov 15. Review.

PMID:
25399911
3.

An update on RNA interference-mediated gene silencing in cancer therapy.

Ren YJ, Zhang Y.

Expert Opin Biol Ther. 2014 Nov;14(11):1581-92. doi: 10.1517/14712598.2014.935334. Epub 2014 Jul 10. Review.

PMID:
25010067
4.

Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.

DeVincenzo JP.

Early Hum Dev. 2009 Oct;85(10 Suppl):S31-5. doi: 10.1016/j.earlhumdev.2009.08.013. Epub 2009 Oct 14.

PMID:
19833462
5.

siRNA delivery systems for cancer treatment.

Oh YK, Park TG.

Adv Drug Deliv Rev. 2009 Aug 10;61(10):850-62. doi: 10.1016/j.addr.2009.04.018. Epub 2009 May 5. Review.

PMID:
19422869
6.

Polycation-based nanoparticle delivery for improved RNA interference therapeutics.

Howard KA, Kjems J.

Expert Opin Biol Ther. 2007 Dec;7(12):1811-22. Review.

PMID:
18034647
7.

Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review.

Chaturvedi K, Ganguly K, Kulkarni AR, Kulkarni VH, Nadagouda MN, Rudzinski WE, Aminabhavi TM.

Expert Opin Drug Deliv. 2011 Nov;8(11):1455-68. doi: 10.1517/17425247.2011.610790. Epub 2011 Aug 26. Review.

PMID:
21867463
8.

Advances in targeted delivery of small interfering RNA using simple bioconjugates.

Nielsen C, Kjems J, Sørensen KR, Engelholm LH, Behrendt N.

Expert Opin Drug Deliv. 2014 May;11(5):791-822. doi: 10.1517/17425247.2014.896898. Epub 2014 Mar 26. Review.

PMID:
24669756
9.

In vivo application of RNA interference: from functional genomics to therapeutics.

Lu PY, Xie F, Woodle MC.

Adv Genet. 2005;54:117-42. Review.

PMID:
16096010
10.

Delivery strategies for siRNA-mediated gene silencing.

Gilmore IR, Fox SP, Hollins AJ, Akhtar S.

Curr Drug Deliv. 2006 Apr;3(2):147-5. Review.

PMID:
16611001
11.

Therapeutic potential of RNA interference against cancer.

Takeshita F, Ochiya T.

Cancer Sci. 2006 Aug;97(8):689-96. Review.

12.

Pharmacogenomics-based RNA interference nanodelivery: focus on solid malignant tumors.

Rosen Y, Upadhyay UM, Elman NM.

Expert Opin Drug Deliv. 2012 Jul;9(7):755-66. doi: 10.1517/17425247.2012.685932. Epub 2012 Jun 4. Review.

PMID:
22658087
13.

Targeted delivery of short interfering RNAs--strategies for in vivo delivery.

Wullner U, Neef I, Tur MK, Barth S.

Recent Pat Anticancer Drug Discov. 2009 Jan;4(1):1-8. Review.

PMID:
19149683
14.

Use of RNA interference to minimize ischemia reperfusion injury.

Zhang ZX, Min WP, Jevnikar AM.

Transplant Rev (Orlando). 2012 Apr;26(2):140-55. doi: 10.1016/j.trre.2011.03.001. Epub 2011 Oct 13.

PMID:
22000663
15.

Cationic nanosystems for the delivery of small interfering ribonucleic acid therapeutics: a focus on toxicogenomics.

Akhtar S.

Expert Opin Drug Metab Toxicol. 2010 Nov;6(11):1347-62. doi: 10.1517/17425255.2010.518611. Epub 2010 Oct 7. Review.

PMID:
20929276
16.

The design and exogenous delivery of siRNA for post-transcriptional gene silencing.

Gilmore IR, Fox SP, Hollins AJ, Sohail M, Akhtar S.

J Drug Target. 2004 Jul;12(6):315-40. Review.

PMID:
15545082
17.

RNA interference as an anticancer therapy: a patent perspective.

Dykxhoorn DM.

Expert Opin Ther Pat. 2009 Apr;19(4):475-91. doi: 10.1517/13543770902838008. Review.

PMID:
19441927
18.

A review of the current status of siRNA nanomedicines in the treatment of cancer.

Resnier P, Montier T, Mathieu V, Benoit JP, Passirani C.

Biomaterials. 2013 Sep;34(27):6429-43. doi: 10.1016/j.biomaterials.2013.04.060. Epub 2013 May 30. Review.

PMID:
23727262
19.

Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.

Deng Y, Wang CC, Choy KW, Du Q, Chen J, Wang Q, Li L, Chung TK, Tang T.

Gene. 2014 Apr 1;538(2):217-27. doi: 10.1016/j.gene.2013.12.019. Epub 2014 Jan 7. Review.

PMID:
24406620
20.

Systemic delivery of small RNA using lipid nanoparticles.

Asai T, Oku N.

Biol Pharm Bull. 2014;37(2):201-5. Review.

Supplemental Content

Support Center